Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Bellus Health Inc (BLU)

Bellus Health Inc (BLU)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 874,266
  • Shares Outstanding, K 106,748
  • Annual Sales, $ 20 K
  • Annual Income, $ -71,220 K
  • 60-Month Beta 0.19
  • Price/Sales 55,041.93
  • Price/Cash Flow N/A
  • Price/Book 3.23
Trade BLU with:

Options Overview Details

View History
  • Implied Volatility 84.53% ( +13.30%)
  • Historical Volatility 90.77%
  • IV Percentile 14%
  • IV Rank 11.39%
  • IV High 365.01% on 08/06/21
  • IV Low 48.49% on 08/05/21
  • Put/Call Vol Ratio 5.00
  • Today's Volume 12
  • Volume Avg (30-Day) 95
  • Put/Call OI Ratio 0.46
  • Today's Open Interest 4,875
  • Open Int (30-Day) 5,102

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/22
See More
  • Average Estimate -0.17
  • Number of Estimates 4
  • High Estimate -0.15
  • Low Estimate -0.20
  • Prior Year -0.23
  • Growth Rate Est. (year over year) +26.09%

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.35 +28.98%
on 05/11/22
9.09 -9.90%
on 05/03/22
unch (unch)
since 04/22/22
3-Month
5.45 +50.28%
on 03/15/22
9.09 -9.90%
on 05/03/22
+2.19 (+36.50%)
since 02/23/22
52-Week
2.60 +215.00%
on 07/19/21
9.84 -16.77%
on 12/13/21
+4.31 (+111.08%)
since 05/21/21

Most Recent Stories

More News
Is Bellus Health (BLU) Stock Outpacing Its Medical Peers This Year?

Here is how Bellus Health (BLU) and Adherex Technologies Inc. (FENC) have performed compared to their sector so far this year.

BLU : 8.19 (-0.73%)
FENC : 5.62 (-3.10%)
Wall Street Analysts Believe Bellus (BLU) Could Rally 32%: Here's is How to Trade

The average of price targets set by Wall Street analysts indicates a potential upside of 31.6% in Bellus (BLU). While the effectiveness of this highly sought-after metric is questionable, the positive...

BLU : 8.19 (-0.73%)
BELLUS Health Reports First Quarter 2022 Financial Results and Business Highlights

BELLUS Health Inc. (Nasdaq: BLU; TSX: BLU) (“BELLUS Health” or the “Company”), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of refractory chronic cough...

BLU : 8.19 (-0.73%)
BLU.TO : 10.59 (-2.58%)
BELLUS Health to Present Late-Breaking Clinical Data from the Phase 2b SOOTHE Trial of BLU-5937 at the ATS 2022 International Conference

BELLUS Health Inc. (Nasdaq:BLU; TSX:BLU) (“BELLUS Health” or the “Company”), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of refractory chronic cough...

BLU : 8.19 (-0.73%)
BLU.TO : 10.59 (-2.58%)
BELLUS Health to Participate in Multiple Upcoming Investor Conferences

BELLUS Health Inc. (Nasdaq:BLU; TSX:BLU) (“BELLUS Health” or the “Company”), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of refractory chronic cough...

BLU : 8.19 (-0.73%)
BLU.TO : 10.59 (-2.58%)
Is Bellus Health (BLU) Outperforming Other Medical Stocks This Year?

Here is how Bellus Health (BLU) and Innoviva (INVA) have performed compared to their sector so far this year.

BLU : 8.19 (-0.73%)
INVA : 16.35 (+0.37%)
First Week of June 17th Options Trading For BELLUS Health (BLU)

Investors in BELLUS Health Inc saw new options begin trading this week, for the June 17th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the BLU options chain for...

BLU : 8.19 (-0.73%)
Sanofi (SNY) Stock Outperforms Industry YTD: What Lies Ahead?

Here we discuss some factors that have been driving Sanofi's (SNY) stock and its outlook for the future.

REGN : 681.91 (+3.14%)
SNY : 55.43 (+1.89%)
SLDB : 0.5248 (-3.87%)
BLU : 8.19 (-0.73%)
Vertex (VRTX) Stock Rallies 27% in a Year: What Lies Ahead?

In 2022, Vertex (VRTX) expects continued revenue growth as there are more than 25,000 patients who are addressable with Vertex's CF therapies.

VRTX : 268.35 (+3.77%)
MRNA : 137.62 (+1.01%)
CRSP : 54.71 (-2.89%)
BLU : 8.19 (-0.73%)
Alnylam's (ALNY) Vutrisiran NDA Faces Delay in FDA Decision

The FDA needs time to review new information incorporated into Alnylam's (ALNY) vutrisiran NDA related to a new secondary packaging and labeling facility, which has been cited as a reason for the delay...

ALNY : 129.58 (-2.03%)
SLDB : 0.5248 (-3.87%)
BLU : 8.19 (-0.73%)
ALGS : 1.1700 (+8.33%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

BELLUS Health is a global health company focused on the development and commercialization of products to provide innovative health solutions to address critical unmet medical needs.

See More

Key Turning Points

3rd Resistance Point 8.61
2nd Resistance Point 8.48
1st Resistance Point 8.34
Last Price 8.19
1st Support Level 8.07
2nd Support Level 7.94
3rd Support Level 7.80

See More

52-Week High 9.84
Last Price 8.19
Fibonacci 61.8% 7.07
Fibonacci 50% 6.22
Fibonacci 38.2% 5.37
52-Week Low 2.60

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar